Sale!

Dengue Virus and Chikungunya Virus RNA Detection Qualitative Test

750 د.إ

-25%

The Dengue Virus and Chikungunya Virus RNA Detection Qualitative Test is a sophisticated diagnostic procedure available at DNA Labs UAE, designed to accurately identify the presence of the RNA of both the Dengue and Chikungunya viruses in a patient’s blood sample. This test is crucial for the timely diagnosis of these viral infections, which are both transmitted by mosquitoes and have similar clinical presentations, including fever, joint pain, and rash, but require different management strategies.

Utilizing advanced molecular techniques, this test qualitatively assesses the RNA of the viruses, providing a clear indication of an active infection. This is particularly important in areas where these diseases are endemic or during outbreaks, as it allows for the rapid initiation of appropriate treatment and management measures to mitigate the spread and impact of these illnesses.

The cost of the Dengue Virus and Chikungunya Virus RNA Detection Qualitative Test at DNA Labs UAE is set at 750 AED. This price reflects the sophisticated nature of the testing technology and the expertise required to accurately interpret the results. Patients seeking this test can expect a high standard of diagnostic accuracy, contributing to better health outcomes and the effective management of these potentially serious viral infections.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Dengue Virus and Chikungunya Virus RNA Detection Qualitative Test

Cost: AED 750.0

Test Details

The Dengue Virus and Chikungunya Virus RNA Detection Qualitative Test is a diagnostic tool used to detect the presence of RNA from these two viruses in a patient’s blood sample. Both Dengue and Chikungunya are viral infections transmitted by mosquitoes and can cause similar symptoms such as fever, joint pain, and rash.

The test utilizes a molecular technique called reverse transcription-polymerase chain reaction (RT-PCR) to amplify and detect specific RNA sequences from the viruses. The test can identify the viral RNA even in the early stages of infection when the viral load is low.

The qualitative nature of the test means that it can determine whether the virus is present or absent in the patient’s sample. It cannot provide information on the viral load or the severity of the infection.

Test Components and Price

  • Test Name: Dengue Virus and Chikungunya Virus RNA Detection Qualitative Test
  • Price: AED 750.0

Sample Condition

The test can be performed on whole blood, serum, plasma, or cerebrospinal fluid (C.S.F).

Report Delivery

The test results will be delivered via email within 36 hours on the 3rd working day. Results can also be obtained over the phone within 24 hours.

Method

The test utilizes Real Time PCR (Polymerase Chain Reaction) method.

Test Type

The test is classified as a viral test.

Doctor

The test is typically ordered by a physician.

Test Department

The test is performed in the Genetics department of DNA Labs UAE.

Pre Test Information

Prior to the test, the patient needs to sign a consent document and provide any relevant clinical history for Dengue Virus and Chikungunya Virus (RNA Detection) Qualitative Test.

Importance of the Test

The early detection of Dengue and Chikungunya viral infections is crucial for appropriate management and treatment. Identifying the specific virus causing the symptoms can help guide treatment decisions and prevent further spread of the infection.

It is important to note that this test is specific for detecting RNA from Dengue and Chikungunya viruses and does not detect other viral infections or provide information about immunity to these viruses. Other tests, such as serological tests, may be needed to confirm the diagnosis and determine the patient’s immune status.

Test Name Dengue Virus and Chikungunya Virus RNA Detection Qualitative Test
Components
Price 750.0 AED
Sample Condition Whole Blood, Serum, Plasma, C.S.F
Report Delivery 3rd Working Day Email:-36 hours. On phone: 24 hours
Method Real Time PCR
Test type Viral
Doctor Physician
Test Department: Genetics
Pre Test Information Need to sign Consent document and bring any clinical history of patient forDengue Virus and Chikungunya Virus (RNA Detection) QualitativeTest
Test Details

The Dengue Virus and Chikungunya Virus (RNA Detection) Qualitative Test is a diagnostic tool used to detect the presence of RNA from these two viruses in a patient’s blood sample. Both Dengue and Chikungunya are viral infections transmitted by mosquitoes and can cause similar symptoms such as fever, joint pain, and rash.

The test utilizes a molecular technique called reverse transcription-polymerase chain reaction (RT-PCR) to amplify and detect specific RNA sequences from the viruses. The test can identify the viral RNA even in the early stages of infection when the viral load is low.

The qualitative nature of the test means that it can determine whether the virus is present or absent in the patient’s sample. It cannot provide information on the viral load or the severity of the infection.

The Dengue Virus and Chikungunya Virus (RNA Detection) Qualitative Test is typically performed in specialized laboratories equipped with the necessary equipment and expertise to handle and process RNA samples. The test is usually ordered by healthcare providers when there is a suspicion of Dengue or Chikungunya infection based on the patient’s symptoms and exposure history.

Early detection of these viral infections is crucial for appropriate management and treatment. Identifying the specific virus causing the symptoms can help guide treatment decisions and prevent further spread of the infection.

It is important to note that this test is specific for detecting RNA from Dengue and Chikungunya viruses and does not detect other viral infections or provide information about immunity to these viruses. Other tests, such as serological tests, may be needed to confirm the diagnosis and determine the patient’s immune status.